Angewandte
Chemie
DOI: 10.1002/anie.201400420
À
C H Activation
À
A Convenient Photocatalytic Fluorination of Unactivated C H
Bonds**
Shira D. Halperin, Hope Fan, Stanley Chang, Rainer E. Martin, and Robert Britton*
À
Abstract: Fluorination reactions are essential to modern
medicinal chemistry, thus providing a means to block site-
selective metabolic degradation of drugs and access radio-
tracers for positron emission tomography imaging. Despite
current sophistication in fluorination reagents and processes,
fluorination of C H bonds. In this context, success has been
realized in allylic[10] and benzylic[11] fluorination. However,
the identification of reagent systems that effect selective
3
À
fluorination of unactivated C(sp ) H bonds, or those not
adjacent to sp2-hybridized carbon atoms or other functional
groups, which facilitate the formation of radicals or anions,
remains a significant challenge.[12]
À
the fluorination of unactivated C H bonds remains a signifi-
cant challenge. Reported herein is a convenient and economic
À
process for direct fluorination of unactivated C H bonds that
Recently, Groves and co-workers disclosed a protocol for
À
exploits the hydrogen abstracting ability of a decatungstate
photocatalyst in combination with the mild fluorine atom
transfer reagent N-fluorobenzenesulfonimide. This operation-
ally straightforward reaction provides direct access to a wide
range of fluorinated organic molecules, including structurally
complex natural products, acyl fluorides, and fluorinated
amino acid derivatives.
the fluorination of unactivated C H bonds through a radical
process which relies on a manganese porphyrin catalyst
working in concert with an oxidant (iodosylbenzene), AgF,
and a catalytic amount of tetrabutylammonium fluoride
(TBAF).[12] The groups of Lectka[13] and Inoue[14] have also
demonstrated that N-oxyl radicals are capable of catalyzing
3
À
the fluorination of C(sp ) H bonds in unfunctionalized
cycloalkanes (e.g., cyclohexane, cyclooctane) when using
Selectfluor as the fluorine-transfer reagent. An earlier
report by Sandford, Chambers, and co-workers also describes
a catalyst-free electrophilic fluorination reaction of hydro-
carbons using Selectfluor in refluxing MeCN.[15] For the
reasons discussed above, we have been interested in devel-
T
he incorporation of a fluorine atom into an advanced drug
candidate is a common strategy in medicinal chemistry.[1,2]
Oftentimes, single hydrogen to fluorine substitution
a
improves druglike properties by blocking undesired metab-
olism at a specific site, increasing lipophilicity or binding
affinity, or altering drug absorption, distribution, or excre-
tion.[1] In addition to the medicinal advantages often pre-
sented by fluorination, valuable pharmacokinetic information
can be gleaned from non-invasive positron emission tomog-
raphy (PET) imaging of 18F-labeled drugs in vivo.[3] The
critical role fluorine plays in the drug discovery process is
highlighted by the fact that one-third of the so-called block-
buster drugs are fluorinated in at least one position.[4] Since
the fluorination of cortisone[5] signalled a new era of
fluoropharmaceuticals, further advances have relied on the
discovery of mild fluorination reagents which can be handled
safely and obviate the use of fluorine gas or its surrogates.[2,6]
While present sophistication in the field includes the addition
of electrophilic fluorine to alkenes,[6,7] and fluorination of aryl
triflates[8] and palladium aryl complexes,[9] there is much
interest in the development of reactions that effect the direct
oping a convenient protocol for the direct fluorination of
3
À
unactivated C(sp ) H bonds, and were particularly intrigued
by a process that would involve the generation and trapping
of alkyl radicals with fluorine-transfer reagents. In this regard,
Sammis and co-workers have calculated[16] the homolytic N F
À
bond dissociation energy (BDE) for several electrophilic
fluorinating reagents, including N-fluorobenzenesulfonimide
(NFSI; BDENF = 63 kcalmolÀ1), and demonstrated the utility
of NFSI in fluorine transfer to alkyl radicals generated
through decarboxylative processes.[17] Considering that [18F]-
NFSI can be readily prepared from the reaction of [18F]F2 and
NaN(SO2Ph)2,[18] the development of a NFSI-based fluorina-
3
À
tion of unactivated C(sp ) H bonds could also serve as
a platform technology for the production of new radiotracers
for PET imaging. Bearing this in mind, we envisioned
a reaction which combines the hydrogen abstraction ability
of a polyoxometalate with a fluorine-transfer reagent to
3
À
À
[*] S. D. Halperin, H. Fan, S. Chang, Prof. R. Britton
Department of Chemistry, Simon Fraser University
Burnaby, British Columbia (Canada)
directly transform unactivated C(sp ) H bonds into C F
bonds.
A variety of polyoxometalates have proven effective as
E-mail: rbritton@sfu.ca
photocatalysts in oxidative transformations,[19] and the deca-
Dr. R. E. Martin
4À
tungstate anion W10O32 has been studied extensively for
Medicinal Chemistry, Small Molecule Research, Pharma Research &
Early Development (pRED), F. Hoffmann-La Roche AG
Grenzacherstrasse 124, 4070 Basel (Switzerland)
these purposes.[20-22] The tetrabutylammonium salt of deca-
tungstate (TBADT; 3; Table 1) is a well-characterized
polyoxometalate catalyst which is particularly efficient at
abstracting hydrogen atoms from saturated hydrocarbons[21]
and has been utilized in carbon–carbon bond formation,[23]
[**] This work was supported by an NSERC Discovery Grant to R.B.,
a MSFHR Career Investigator Award to R.B., and NSERC Post-
graduate Scholarships for S.D.H., H.F., S.C.
oxidation of alcohols,[24] epimerization of unactivated C H
À
Supporting information for this article is available on the WWW
centers,[25] and carbonylation reactions.[26] From a practical
Angew. Chem. Int. Ed. 2014, 53, 1 – 5
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1
These are not the final page numbers!